Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21M Buy
157,500
+2,500
+2% +$283K 10.19% 2
2026
Q1
$17.3M Buy
155,000
+51,500
+50% +$6.09M 3.93% 3
2025
Q4
$14M Buy
+103,500
New +$11.3M 3.22% 5

Other funds holding ABVX

Creek Drive Management Group's ABVX Position: Q2 2026 in Review

Creek Drive Management Group increased its Abivax (ABVX) stake by 1.6% in Q2 2026, buying an estimated $283K and bringing the position to 157,500 shares worth $21M. The position accounts for 10.19% of the portfolio, ranked #2.

Creek Drive Management Group first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Creek Drive Management Group held 157,500 shares of Abivax worth $21M as of Q2 2026.
  • Creek Drive Management Group bought 2,500 Abivax shares in Q2 2026, an estimated $283K.
  • Abivax made up 10.19% of Creek Drive Management Group's portfolio in Q2 2026, its #2 holding.
  • Creek Drive Management Group first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Creek Drive Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.